Physician profile
John S Gilbert
NPI 1275735581
$24,353.01
in general payments reported to CMS, 2019-2025
23 companies · $17K in 2025
The $17K reported for 2025 was more than what 98% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,938 · 2020: $1,100 · 2021: $509 · 2022: $1,161 · 2023: $868 · 2024: $1,914 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $5,072 · Travel and Lodging: $340 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,200.00 |
| Food and Beverage | $5,072.27 |
| Travel and Lodging | $340.03 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spirair, INC. | $15,283.50 | 2024-2025 | Septalign |
| Aerin Medical INC. | $3,835.32 | 2019-2025 | |
| Stryker Corporation | $1,584.75 | 2019-2025 | Scopis Ent, Audion Et Dilation System |
| Acclarent, INC | $898.82 | 2020-2024 | Trudi Nav Cable, Acclarent Aera, Relieva Spinplus |
| Integra Lifesciences Corporation | $419.46 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $373.98 | 2019-2025 | Halo |
| Inspire Medical Systems, INC. | $361.69 | 2024-2025 | Inspire |
| Neurent Medical Limited | $360.27 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Medtronic, INC. | $349.51 | 2023-2025 | Propel, Sinuva, Nuvent |
| Intersect Ent, INC. | $213.69 | 2019-2021 | |
| Glaxosmithkline, LLC. | $133.65 | 2022-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $132.79 | 2021-2025 | Dupixent |
| Genzyme Corporation | $111.08 | 2024-2025 | |
| Medtronic USA, INC. | $87.76 | 2020 | |
| Amgen INC. | $52.64 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.46 | 2025 | Ethicon, Vistaseal |
| Acelrx Pharmaceuticals, INC. | $22.03 | 2022 | |
| Lilly USA, LLC | $19.61 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $19.57 | 2025 | Keytruda |
| Karl Storz Endoscopy-America | $18.76 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.51 | 2025 | |
| Organogenesis INC. | $14.83 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.